Excretion, metabolism, and pharmacokinetics of 1-(8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl)-4-(ethylamino)piperidine-4-carboxamide, a selective cannabinoid receptor antagonist, in healthy male volunteers.
Drug metabolism and disposition: the biological fate of chemicals • Vol. 40, Issue 3 • 2012
Excretion, metabolism, and pharmacokinetics of CP-945,598, a selective cannabinoid receptor antagonist, in rats, mice, and dogs.
Drug metabolism and disposition: the biological fate of chemicals • Vol. 39, Issue 12 • 2011
Efficacy and safety of CP-945,598, a selective cannabinoid CB1 receptor antagonist, on weight loss and maintenance.
Obesity (Silver Spring, Md.) • Vol. 19, Issue 7 • 2011
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.
Journal of obesity • Vol. 2011 • 2011
